GRI Bio (GRI) reported interim 6-week lung function results from its ongoing Phase 2a study evaluating GRI-0621 for the treatment of Idiopathic ...

In the second interim analysis, lung function was assessed from the first 24 subjects at 6 weeks. GRI-0621 treated patients demonstrated no worsening of forced vital capacity ("FVC”) at 6 weeks ...

Researchers have developed a method that combines AFM and AI to accurately profile macrophage mechanophenotypes.

Spectral Flow Cytometry Pioneer Unveils Innovations Accelerating Efficiency and DiscoveryFREMONT, Calif., Sept. 10, 2025 (GLOBE NEWSWIRE) -- With cancer research and diagnostics driving the need for ...

Macrophages drive key immune processes including inflammation, tissue repair, and tumorigenesis via distinct polarization ...

Cytek Biosciences, Inc. ( NASDAQ: CTKB) Morgan Stanley 23rd Annual Global Healthcare Conference September 10, 2025 10:00 AM EDT ...

Cytek has reported relatively small net losses, indicating that its financial position has not deteriorated significantly.

From lucky tokens that keep instruments running smoothly to a weekly cookie break, scientists told us about their favorite ...

H OUSTON -- Complete response (CR) rates in relapsed/refractory NPM1 -mutated acute myeloid leukemia (AML) doubled historical ...

Thermo Fisher Scientific introduces next-generation unmixing beads to enhance accuracy and performance in spectral and conventional flow cytometry Thermo Fisher Scientific has introduced Invitrogen™ ...

Key industry drivers include advancements in reagent technologies and increasing demand across research, clinical diagnostics, and drug development. Asia-Pacific is set to witness the fastest growth, ...

Introduction Critically ill patients commonly develop acquired neutrophil dysfunction, which increases susceptibility to intensive care unit-acquired infection (ICU-AI). This study aimed to assess ...